51Թapp

Professor Jeff Holst

Professor Jeff Holst

Professor

BSc (Hons), PhD

Medicine & Health
School of Biomedical Sciences

I am a fundamental and translational cancer researcher developing new ways to profile and target metabolic pathways in melanoma, glioblastoma, breast and prostate cancer. My research has focussed primarily on the role of uptake and metabolism of amino acids by cancer cells and how these integrate and cooperate with glucose metabolism to drive cell growth. My lab has developed a range of novel methods for exploring these metabolic processes in cancer, including 3D explant models for analysis of metabolism (metabolomics) and therapeutic development.

I am Director of Engagement and Industry Partnerships in the School of Biomedical Sciences at UNSW, and Director of the Adult Cancer Program. In addition, I am part of the Strategic Advisory Committee of the UNSW Cancer Theme.

Phone
+61-2-9065 8953
Location
Level 2 | Lowy Cancer Research Centre C25 UNSW SYDNEY NSW 2052 AUSTRALIA
  • Books | 2006
    Holst J; Rasko JEJ, 2006, The Use of Retroviral Vectors for Gene Transfer into Hematopoietic Stem Cells,
  • Journal articles | 2024
    Filipe EC; Velayuthar S; Philp A; Nobis M; Latham SL; Parker AL; Murphy KJ; Wyllie K; Major GS; Contreras O; Mok ETY; Enriquez RF; McGowan S; Feher K; Quek LE; Hancock SE; Yam M; Tran E; Setargew YFI; Skhinas JN; Chitty JL; Phimmachanh M; Han JZR; Cadell AL; Papanicolaou M; Mahmodi H; Kiedik B; Junankar S; Ross SE; Lam N; Coulson R; Yang J; Zaratzian A; Da Silva AM; Tayao M; Chin IL; Cazet A; Kansara M; Segara D; Parker A; Hoy AJ; Harvey RP; Bogdanovic O; Timpson P; Croucher DR; Lim E; Swarbrick A; Holst J; Turner N; Choi YS; Kabakova IV; Philp A; Cox TR, 2024, 'Tumor Biomechanics Alters Metastatic Dissemination of Triple Negative Breast Cancer via Rewiring Fatty Acid Metabolism', Advanced Science, 11,
    Journal articles | 2024
    Johnson KK; Koshy P; Kopecky C; Devadason M; Biazik J; Zheng X; Jiang Y; Wang X; Liu Y; Holst J; Yang JL; Kilian KA; Sorrell CC, 2024, 'ROS-mediated anticancer effects of EGFR-targeted nanoceria', Journal of Biomedical Materials Research - Part A, 112, pp. 754 - 769,
    Journal articles | 2024
    Wahi K; Freidman N; Wang Q; Devadason M; Quek LE; Pang A; Lloyd L; Larance M; Zanini F; Harvey K; O’Toole S; Guan YF; Holst J, 2024, 'Macropinocytosis mediates resistance to loss of glutamine transport in triple-negative breast cancer', EMBO Journal,
    Journal articles | 2023
    Dewdney B; Jenkins MR; Best SA; Freytag S; Prasad K; Holst J; Endersby R; Johns TG, 2023, 'From signalling pathways to targeted therapies: unravelling glioblastoma’s secrets and harnessing two decades of progress', Signal Transduction and Targeted Therapy, 8,
    Journal articles | 2023
    K. Johnson K; Kopecky C; Koshy P; Liu Y; Devadason M; Holst J; A. Kilian K; C. Sorrell C, 2023, 'Theranostic Activity of Ceria-Based Nanoparticles toward Parental and Metastatic Melanoma: 2D vs 3D Models', ACS Biomaterials Science and Engineering, 9, pp. 1053 - 1065,
    Journal articles | 2023
    Wang NF; Jue TR; Holst J; Gunter JH, 2023, 'Systematic review of antitumour efficacy and mechanism of metformin activity in prostate cancer models', BJUI Compass, 4, pp. 44 - 58,
    Journal articles | 2022
    Dylgjeri E; Kothari V; Shafi AA; Semenova G; Gallagher PT; Guan YF; Pang A; Goodwin JF; Irani S; McCann JJ; Mandigo AC; Chand S; McNair CM; Vasilevskaya I; Schiewer MJ; Lallas CD; McCue PA; Gomella LG; Seifert EL; Carroll JS; Butler LM; Holst J; Kelly WK; Knudsen KE, 2022, 'A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate Cancer', Clinical Cancer Research, 28, pp. 1446 - 1459,
    Journal articles | 2022
    Leiske MN; Mazrad ZAI; Zelcak A; Wahi K; Davis TP; McCarroll JA; Holst J; Kempe K, 2022, 'Zwitterionic Amino Acid-Derived Polyacrylates as Smart Materials Exhibiting Cellular Specificity and Therapeutic Activity', Biomacromolecules, 23, pp. 2374 - 2387,
    Journal articles | 2022
    Quek LE; van Geldermalsen M; Guan YF; Wahi K; Mayoh C; Balaban S; Pang A; Wang Q; Cowley MJ; Brown KK; Turner N; Hoy AJ; Holst J, 2022, 'Glutamine addiction promotes glucose oxidation in triple-negative breast cancer', Oncogene, 41, pp. 4066 - 4078,
    Journal articles | 2021
    Gillis JL; Hinneh JA; Ryan N; Irani S; Moldovan M; Quek LE; Shrestha R; Hanson AR; Xie J; Hoy AJ; Holst J; Centenera MM; Mills IG; Lynn DJ; Selth LA; Butler LM, 2021, 'A feedback loop between the 1 androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growth: Cooperativity between 6PGD and AR drives prostate cancer growth', eLife, 10, pp. e62592,
    Journal articles | 2021
    Mandigo AC; Yuan W; Xu K; Gallagher P; Pang A; Guan YF; Shafi AA; Thangavel C; Sheehan B; Bogdan D; Paschalis A; McCann JJ; Laufer TS; Gordon N; Vasilevskaya IA; Dylgjeri E; Chand SN; Schiewer MJ; Domingo-Domenech J; Den RB; Holst J; McCue PA; de Bono JS; McNair C; Knudsen KE, 2021, 'Rb/e2f1 as a master regulator of cancer cell metabolism in advanced disease', Cancer Discovery, 11, pp. 2334 - 2353,
    Journal articles | 2021
    Noor H; Briggs NE; McDonald KL; Holst J; Vittorio O, 2021, 'Tp53 mutation is a prognostic factor in lower grade glioma and may influence chemotherapy efficacy', Cancers, 13, pp. 5362,
    Journal articles | 2021
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2021, 'Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma determine response to slc7a11 inhibition', Cancer Research, 81, pp. 3461 - 3479,
    Journal articles | 2021
    Wang Q; Guan YF; Hancock SE; Wahi K; van Geldermalsen M; Zhang BK; Pang A; Nagarajah R; Mak B; Freidman N; Horvath LG; Turner N; Holst J, 2021, 'Inhibition of guanosine monophosphate synthetase (GMPS) blocks glutamine metabolism and prostate cancer growth', Journal of Pathology, 254, pp. 135 - 146,
    Journal articles | 2020
    Freidman N; Chen I; Wu Q; Briot C; Holst J; Font J; Vandenberg R; Ryan R, 2020, 'Amino Acid Transporters and Exchangers from the SLC1A Family: Structure, Mechanism and Roles in Physiology and Cancer', Neurochemical Research, 45, pp. 1268 - 1286,
    Journal articles | 2020
    Huxley C; Wibowo M; Lum KY; Gordon S; D'Hyon S; Guan H; Wang X; Chen Y; Si M; Wang M; White JM; Wahi K; Wang Q; Holst J; Davis RA, 2020, 'Synthesis of bilocularin A carbamate derivatives and their evaluation as leucine transport inhibitors in prostate cancer cells', Phytochemistry, 179, pp. 112478,
    Journal articles | 2020
    Mandigo AC; McNair C; Ku K; Pang A; Guan YF; Holst J; Brown M; Kelly WK; Knudsen KE, 2020, 'Molecular underpinnings of RB status as a biomarker of poor outcome in advanced prostate cancer.', Journal of Clinical Oncology, 38, pp. 189 - 189,
    Journal articles | 2020
    Nassar ZD; Mah CY; Dehairs J; Burvenich IJG; Irani S; Centenera MM; Helm M; Shrestha RK; Moldovan M; Don AS; Holst J; Scott AM; Horvath LG; Lynn DJ; Selth LA; Hoy AJ; Swinnen JV; Butler LM, 2020, 'Human decr1 is an androgen-repressed survival factor that regulates pufa oxidation to protect prostate tumor cells from ferroptosis', eLife, 9, pp. 1 - 34,
    Journal articles | 2020
    Wang Q; Guan Y; Hancock S; Wahi K; van Geldermalsen M; Zhang B; Pang A; Nagarajah R; Mak B; Horvath L; Turner N; Holst J, 2020, 'Inhibition of guanosine monophosphate synthetase (GMPS) blocks glutamine metabolism and prostate cancer growthin vitroandin vivo', ,
    Journal articles | 2019
    Balaban S; Nassar ZD; Zhang AY; Hosseini-Beheshti E; Centenera MM; Schreuder M; Lin HM; Aishah A; Varney B; Liu-Fu F; Lee LS; Nagarajan SR; Shearer RF; Hardie RA; Raftopulos NL; Kakani MS; Saunders DN; Holst J; Horvath LG; Butler LM; Hoy AJ, 2019, 'Extracellular fatty acids are the major contributor to lipid synthesis in prostate cancer', Molecular Cancer Research, 17, pp. 949 - 962,
    Journal articles | 2019
    Bröer A; Gauthier-Coles G; Rahimi F; van Geldermalsen M; Dorsch D; Wegener A; Holst J; Bröer S, 2019, 'Ablation of the ASCT2 (SLC1A5) gene encoding a neutral amino acid transporter reveals transporter plasticity and redundancy in cancer cells', Journal of Biological Chemistry, 294, pp. 4012 - 4026,
    Journal articles | 2019
    Gao D; Pinello N; Nguyen TV; Thoeng A; Nagarajah R; Holst J; Rasko JEJ; Wong JJL, 2019, 'DNA methylation/hydroxymethylation regulate gene expression and alternative splicing during terminal granulopoiesis', Epigenomics, 11, pp. 95 - 109,
    Journal articles | 2019
    Gide TN; Quek C; Menzies AM; Tasker AT; Shang P; Holst J; Madore J; Lim SY; Velickovic R; Wongchenko M; Yan Y; Lo S; Carlino MS; Guminski A; Saw RPM; Pang A; McGuire HM; Palendira U; Thompson JF; Rizos H; Silva IPD; Batten M; Scolyer RA; Long GV; Wilmott JS, 2019, 'Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy', Cancer Cell, 35, pp. 238 - 255.e6,
    Journal articles | 2019
    Gordon S; Wibowo M; Wang Q; Holst J; Davis RA, 2019, 'Dihydro-β-agarofurans from the Australian rainforest plant Denhamia celastroides that inhibit leucine transport in prostate cancer cells', Magnetic Resonance in Chemistry, 57, pp. 101 - 109,
    Journal articles | 2019
    Guo D; Lui GYL; Lai SL; Wilmott JS; Tikoo S; Jackett LA; Quek C; Brown DL; Sharp DM; Kwan RYQ; Chacon D; Wong JH; Beck D; van Geldermalsen M; Holst J; Thompson JF; Mann GJ; Scolyer RA; Stow JL; Weninger W; Haass NK; Beaumont KA, 2019, 'RAB27A promotes melanoma cell invasion and metastasis via regulation of pro-invasive exosomes', International Journal of Cancer, 144, pp. 3070 - 3085,
    Journal articles | 2019
    Wahi K; Holst J, 2019, 'ASCT2: a potential cancer drug target', Expert Opinion on Therapeutic Targets, 23, pp. 555 - 558,
    Journal articles | 2019
    Zhang BK; Moran AM; Bailey CG; Rasko JEJ; Holst J; Wang Q, 2019, 'EGF-activated PI3K/Akt signalling coordinates leucine uptake by regulating LAT3 expression in prostate cancer', Cell Communication and Signaling, 17, pp. 83,
    Journal articles | 2019
    da Silva IP; Wang KYX; Wilmott JS; Holst J; Carlino MS; Park JJ; Quek C; Wongchenko M; Yan Y; Mann G; Johnson DB; McQuade JL; Rai R; Kefford RF; Rizos H; Scolyer RA; Yang JYH; Long GV; Menzies AM, 2019, 'Distinct molecular profiles and immunotherapy treatment outcomes of V600E and V600K BRAF-mutant melanoma', Clinical Cancer Research, 25, pp. 1272 - 1279,
    Journal articles | 2019
    de Bock CE; Down M; Baidya K; Sweron B; Boyd AW; Fiers M; Burns GF; Molloy TJ; Lock RB; Soulier J; Taghon T; Van Vlierberghe P; Cools J; Holst J; Thorne RF, 2019, 'T-cell acute lymphoblastic leukemias express a unique truncated FAT1 isoform that cooperates with NOTCH1 in leukemia development', Haematologica, 104, pp. e204 - e207,
    Journal articles | 2018
    Akerman A; Sharbeen G; Holst J; Youkhana J; McCarroll J; Goldstein D; Erkan M; Phillips P, 2018, 'Targeting a solute carrier to metabolically reprogram tumour-promoting stromal cells in pancreatic cancer', Pancreatology, 18, pp. S156 - S156,
    Journal articles | 2018
    Garibsingh RAA; Otte NJ; Ndaru E; Colas C; Grewer C; Holst J; Schlessinger A, 2018, 'Homology modeling informs ligand discovery for the glutamine transporter ASCT2', Frontiers in Chemistry, 6, pp. 279,
    Journal articles | 2018
    Rajasekhar M; Schmitz U; Flamant S; Wong JJL; Bailey CG; Ritchie W; Holst J; Rasko JEJ, 2018, 'Identifying microRNA determinants of human myelopoiesis', Scientific Reports, 8,
    Journal articles | 2018
    Ryan RM; Holst J, 2018, 'Regulation of SLC1A4 and SLC1A5 in prostate cancer-letter', Molecular Cancer Research, 16, pp. 1809 - 1810,
    Journal articles | 2018
    Thientosapol ES; Bosnjak D; Durack T; Stevanovski I; Van Geldermalsen M; Holst J; Jahan Z; Shepard C; Weninger W; Kim B; Brink R; Jolly CJ, 2018, 'SAMHD1 enhances immunoglobulin hypermutation by promoting transversion mutation', Proceedings of the National Academy of Sciences of the United States of America, 115, pp. 4921 - 4926,
    Journal articles | 2018
    Wibowo M; Wang Q; Holst J; White JM; Hofmann A; Davis RA, 2018, 'Dihydro-β-agarofurans from the roots of the Australian endemic rainforest tree Maytenus bilocularis act as leucine transport inhibitors', Phytochemistry, 148, pp. 71 - 77,
    Journal articles | 2018
    van Geldermalsen M; Quek LE; Turner N; Freidman N; Pang A; Guan YF; Krycer JR; Ryan R; Wang Q; Holst J, 2018, 'Benzylserine inhibits breast cancer cell growth by disrupting intracellular amino acid homeostasis and triggering amino acid response pathways', BMC Cancer, 18, pp. 689,
    Journal articles | 2017
    Balaban S; Shearer RF; Lee LS; van Geldermalsen M; Schreuder M; Shtein HC; Cairns R; Thomas KC; Fazakerley DJ; Grewal T; Holst J; Saunders DN; Hoy AJ, 2017, 'Adipocyte lipolysis links obesity to breast cancer growth: adipocyte-derived fatty acids drive breast cancer cell proliferation and migration', Cancer & Metabolism, 5, pp. 1,
    Journal articles | 2017
    Chen Y; Ma J; Lu W; Tian M; Thauvin M; Yuan C; Volovitch M; Wang Q; Holst J; Liu M; Vriz S; Ye S; Wang L; Li D, 2017, 'Heritable expansion of the genetic code in mouse and zebrafish', Cell Research, 27, pp. 294 - 297,
    Journal articles | 2017
    Guan FHX; Bailey CG; Metierre C; O’Young P; Gao D; Khoo TL; Holst J; Rasko JEJ, 2017, 'The antiproliferative ELF2 isoform, ELF2B, induces apoptosis in vitro and perturbs early lymphocytic development in vivo', Journal of Hematology and Oncology, 10,
    Journal articles | 2017
    Marshall AD; van Geldermalsen M; Otte NJ; Lum T; Vellozzi M; Thoeng A; Pang A; Nagarajah R; Zhang B; Wang Q; Anderson L; Rasko JEJ; Holst J, 2017, 'ASCT2 regulates glutamine uptake and cell growth in endometrial carcinoma', Oncogenesis, 6,
    Journal articles | 2017
    Wibowo M; Wang Q; Holst J; White JM; Hofmann A; Davis RA, 2017, 'Celastrofurans A-G: Dihydro-β-Agarofurans from the Australian Rainforest Vine Celastrus subspicata and Their Inhibitory Effect on Leucine Transport in Prostate Cancer Cells', Journal of Natural Products, 80, pp. 1918 - 1925,
    Journal articles | 2017
    Wong JJL; Gao D; Nguyen TV; Kwok CT; Van Geldermalsen M; Middleton R; Pinello N; Thoeng A; Nagarajah R; Holst J; Ritchie W; Rasko JEJ, 2017, 'Intron retention is regulated by altered MeCP2-mediated splicing factor recruitment', Nature Communications, 8,
    Journal articles | 2017
    Zhao Y; Ting KK; Li J; Cogger VC; Chen J; Johansson-Percival A; Ngiow SF; Holst J; Grau G; Goel S; Muller T; Dejana E; McCaughan G; Smyth MJ; Ganss R; Vadas MA; Gamble JR, 2017, 'Targeting vascular endothelial-cadherin in tumor-associated blood vessels promotes T-cell–mediated immunotherapy', Cancer Research, 77, pp. 4434 - 4447,
    Journal articles | 2016
    Marshall AD; van Geldermalsen M; Otte NJ; Anderson LA; Lum T; Vellozzi MA; Zhang BK; Thoeng A; Wang Q; Rasko JEJ; Holst J, 2016, 'LAT1 is a putative therapeutic target in endometrioid endometrial carcinoma', International Journal of Cancer, 139, pp. 2529 - 2539,
    Journal articles | 2016
    Shklovskaya E; Terry AM; Guy TV; Buckley A; Bolton HA; Zhu E; Holst J; De St Groth BF, 2016, 'Tumour-specific CD4 T cells eradicate melanoma via indirect recognition of tumour-derived antigen', Immunology and Cell Biology, 94, pp. 593 - 603,
    Journal articles | 2016
    Van Geldermalsen M; Wang Q; Nagarajah R; Marshall AD; Thoeng A; Gao D; Ritchie W; Feng Y; Bailey CG; Deng N; Harvey K; Beith JM; Selinger CI; O'Toole SA; Rasko JEJ; Holst J, 2016, 'ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer', Oncogene, 35, pp. 3201 - 3208,
    Journal articles | 2016
    Wibowo M; Levrier C; Sadowski MC; Nelson CC; Wang Q; Holst J; Healy PC; Hofmann A; Davis RA, 2016, 'Bioactive Dihydro-β-agarofuran Sesquiterpenoids from the Australian Rainforest Plant Maytenus bilocularis', Journal of Natural Products, 79, pp. 1445 - 1453,
    Journal articles | 2016
    Wibowo M; Wang Q; Holst J; White JM; Hofmann A; Davis RA, 2016, 'Dihydro-β-agarofurans from the Australian Endemic Rainforest Plant Denhamia pittosporoides Inhibit Leucine Transport in Prostate Cancer Cells', Asian Journal of Organic Chemistry, 5, pp. 1461 - 1466,
    Journal articles | 2016
    Wibowo M; Wang Q; Holst J; White JM; Hofmann A; Davis RA, 2016, 'Inside Cover: Dihydro-β -agarofurans from the Australian Endemic Rainforest Plant Denhamia pittosporoides Inhibit Leucine Transport in Prostate Cancer Cells (Asian J. Org. Chem. 12/2016)', Asian Journal of Organic Chemistry, 5, pp. 1412 - 1412,
    Journal articles | 2016
    Wong JJL; Au AYM; Gao D; Pinello N; Kwok CT; Thoeng A; Lau KA; Gordon JEA; Schmitz U; Feng Y; Nguyen TV; Middleton R; Bailey CG; Holst J; Rasko JEJ; Ritchie W, 2016, 'RBM3 regulates temperature sensitive miR-142-5p and miR-143 (thermomiRs), which target immune genes and control fever', Nucleic Acids Research, 44, pp. 2888 - 2897,
    Journal articles | 2016
    Xi Z; Yao M; Li Y; Xie C; Holst J; Liu T; Cai S; Lao Y; Tan H; Xu HX; Dong Q, 2016, 'Guttiferone K impedes cell cycle re-entry of quiescent prostate cancer cells via stabilization of FBXW7 and subsequent c-MYC degradation', Cell Death and Disease, 7, pp. e2252 - e2252,
    Journal articles | 2015
    Colas C; Grewer C; Gameiro A; Albers T; Singh K; Otte NJ; Shere H; Massimiliano B; Holst J; Schlessinger A, 2015, 'Ligand Discovery for the Alanine-Serine-Cysteine Transporter (ASCT2, SLC1A5) from Homology Modeling and Virtual Screening', BIOPHYSICAL JOURNAL, 108, pp. 54A - 54A,
    Journal articles | 2015
    Colas C; Grewer C; Otte NJ; Gameiro A; Albers T; Singh K; Shere H; Bonomi M; Holst J; Schlessinger A, 2015, 'Ligand Discovery for the Alanine-Serine-Cysteine Transporter (ASCT2, SLC1A5) from Homology Modeling and Virtual Screening', PLoS Computational Biology, 11,
    Journal articles | 2015
    Grkovic T; Pouwer RH; Wang Q; Guymer GP; Holst J; Quinn RJ, 2015, 'LAT Transport Inhibitors from Pittosporum venulosum Identified by NMR Fingerprint Analysis', Journal of Natural Products, 78, pp. 1215 - 1220,
    Journal articles | 2015
    Hnit SST; Xie C; Yao M; Holst J; Bensoussan A; De Souza P; Li Z; Dong Q, 2015, 'P27Kip1 signaling: Transcriptional and post-translational regulation', International Journal of Biochemistry and Cell Biology, 68, pp. 9 - 14,
    Journal articles | 2015
    Leach DA; Need EF; Toivanen R; Trotta AP; Palenthorpe HM; Tamblyn DJ; Kopsaftis T; England GM; Smith E; Drew PA; Pinnock CB; Lee P; Holst J; Risbridger GP; Chopra S; DeFranco DB; Taylor RA; Buchanan G, 2015, 'Erratum: Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome [Oncotarget. 2015; 6:16135-16150]', Oncotarget, 6, pp. 36923,
    Journal articles | 2015
    Leach DA; Need EF; Toivanen R; Trotta AP; Palenthorpe HM; Tamblyn DJ; Kopsaftis T; England GM; Smith E; Drew PA; Pinnock CB; Lee P; Holst J; Risbridger GP; Chopra S; DeFranco DB; Taylor RA; Buchanan G, 2015, 'Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome', Oncotarget, 6, pp. 16135 - 16150,
    Journal articles | 2015
    Wang Q; Hardie RA; Hoy AJ; Van Geldermalsen M; Gao D; Fazli L; Sadowski MC; Balaban S; Schreuder M; Nagarajah R; Wong JJL; Metierre C; Pinello N; Otte NJ; Lehman ML; Gleave M; Nelson CC; Bailey CG; Ritchie W; Rasko JE; Holst J, 2015, 'Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development', Journal of Pathology, 236, pp. 278 - 289,
    Journal articles | 2015
    Wang Q; Holst J, 2015, 'L-type amino acid transport and cancer: Targeting the mTORC1 pathway to inhibit neoplasia', American Journal of Cancer Research, 5, pp. 1281 - 1294
    Journal articles | 2015
    Yao M; Xie C; Kiang MY; Teng Y; Harman D; Tiffen J; Wang Q; Sved P; Bao S; Witting P; Holst J; Dong Q, 2015, 'Targeting of cytosolic phospholipase A2a impedes cell cycle re-entry of quiescent prostate cancer cells', Oncotarget, 6, pp. 34458 - 34474,
    Journal articles | 2015
    van Geldermalsen M; Wang Q; Bailey CG; Feng Y; Nagarajah R; Marshall A; Thoeng A; O'Toole S; Rasko JEJ; Holst J, 2015, 'Targeting the ASCT2 glutamine uptake and metabolism pathway in triple-negative breast cancer', Annals of Oncology, 26, pp. iii31,
    Journal articles | 2014
    Wang Q; Beaumont KA; Otte NJ; Font J; Bailey CG; Van Geldermalsen M; Sharp DM; Tiffen JC; Ryan RM; Jormakka M; Haass NK; Rasko JEJ; Holst J, 2014, 'Targeting glutamine transport to suppress melanoma cell growth', International Journal of Cancer, 135, pp. 1060 - 1071,
    Journal articles | 2014
    Wang Q; Grkovic T; Font J; Bonham S; Pouwer RH; Bailey CG; Moran AM; Ryan RM; Rasko JEJ; Jormakka M; Quinn RJ; Holst J, 2014, 'Monoterpene glycoside ESK246 from pittosporum targets LAT3 amino acid transport and prostate cancer cell growth', ACS Chemical Biology, 9, pp. 1369 - 1376,
    Journal articles | 2014
    Wang Q; Hardie R-A; Balaban S; Schreuder M; Hoy A; van Geldermalsen M; Fazli L; Nagarajah R; Bailey C; Rasko J; Holst J, 2014, 'Inhibition of glutamine uptake regulates mTORC1, glutamine metabolism and cell growth in prostate cancer', CANCER & METABOLISM, 2,
    Journal articles | 2014
    Wong JJL; Holst J, 2014, 'Changes in CpG methylation marks differentiation of human myeloid progenitors to neutrophils.', Stem Cell Investig, 1, pp. 10,
    Journal articles | 2014
    Wong JJL; Ritchie W; Gao D; Lau KA; Gonzalez M; Choudhary A; Taft RJ; Rasko JEJ; Holst J, 2014, 'Identification of nuclear-enriched miRNAs during mouse granulopoiesis', Journal of Hematology and Oncology, 7,
    Journal articles | 2013
    Holst J, 2013, 'Letter to the Editor', International Journal of Pharmaceutics, 455, pp. 393,
    Journal articles | 2013
    Khoo TL; Xiros N; Guan F; Orellana D; Holst J; Joshua DE; Rasko JEJ, 2013, 'Performance evaluation of the abbott CELL-DYN emerald for use as a bench-top analyzer in a research setting', International Journal of Laboratory Hematology, 35, pp. 447 - 456,
    Journal articles | 2013
    Tiffen JC; Bailey CG; Marshall AD; Metierre C; Feng Y; Wang Q; Watson SL; Holst J; Rasko JEJ, 2013, 'The cancer-testis antigen BORIS phenocopies the tumor suppressor CTCF in normal and neoplastic cells', International Journal of Cancer, 133, pp. 1603 - 1613,
    Journal articles | 2013
    Wang Q; Tiffen J; Bailey CG; Lehman ML; Ritchie W; Fazli L; Metierre C; Feng YJ; Li E; Gleave M; Buchanan G; Nelson CC; Rasko JEJ; Holst J, 2013, 'Targeting amino acid transport in metastatic castration-resistant prostate cancer: Effects on cell cycle, cell growth, and tumor development', Journal of the National Cancer Institute, 105, pp. 1463 - 1473,
    Journal articles | 2013
    Wong JJL; Ritchie W; Ebner OA; Selbach M; Wong JWH; Huang Y; Gao D; Pinello N; Gonzalez M; Baidya K; Thoeng A; Khoo TL; Bailey CG; Holst J; Rasko JEJ, 2013, 'XOrchestrated intron retention regulates normal granulocyte differentiation', Cell, 154,
    Journal articles | 2012
    De Bock CE; Ardjmand A; Molloy TJ; Bone SM; Johnstone D; Campbell DM; Shipman KL; Yeadon TM; Holst J; Spanevello MD; Nelmes G; Stewart D; Lincz LF; Boyd AW; Burns GF; Thorne RF, 2012, 'The Fat1 cadherin is overexpressed and an independent prognostic factor for survival in paired diagnosis-relapse samples of precursor B-cell acute lymphoblastic leukemia', Leukemia, 26, pp. 918 - 926,
    Journal articles | 2012
    Wang Q; Bailey CG; Ng C; Tiffen J; Thoeng A; Minnas V; Lehman ML; Hendy SC; Buchanan G; Nelson CC; Rasko JEJ; Holst J, 2012, 'Androgen receptor and nutrient signaling pathways coordinate increased amino acid transport in prostate cancer progression', BMC proceedings, 6, pp. P23 - P23,
    Journal articles | 2011
    Ardjmand A; Bock CED; Molloy TJ; Bone SM; Johnstone D; Campbell DM; Shipman KL; Yeadon TM; Holst J; Spanevello MD; Catchpoole DR; Lincz LF; Boyd AW; Burns GF; Thorne RF, 2011, 'Altered expression of Fat1 cadherin, a novel tumor marker for acute lymphoblastic leukemia', Clinical Biochemistry, 44, pp. S71 - S71,
    Journal articles | 2011
    Bröer A; Juelich T; Vanslambrouck JM; Tietze N; Solomon PS; Holst J; Bailey CG; Rasko JEJ; Bröer S, 2011, 'Impaired nutrient signaling and body weight control in a Na + neutral amino acid cotransporter (Slc6a19)-deficient mouse', Journal of Biological Chemistry, 286, pp. 26638 - 26651,
    Journal articles | 2011
    Wang Q; Bailey CG; Ng C; Tiffen J; Thoeng A; Minhas V; Lehman ML; Hendy SC; Buchanan G; Nelson CC; Rasko JEJ; Holst J, 2011, 'Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression', Cancer Research, 71, pp. 7525 - 7536,
    Journal articles | 2010
    Flamant S; Ritchie W; Guilhot J; Holst J; Bonnet ML; Chomel JC; Guilhot F; Turhan AG; Rasko JEJ, 2010, 'Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia', Haematologica, 95, pp. 1325 - 1333,
    Journal articles | 2010
    Holst J; Watson S; Lord MS; Eamegdool SS; Bax DV; Nivison-Smith LB; Kondyurin A; Ma L; Overhauser AF; Weiss AS; Rasko JEJ, 2010, 'Substrate elasticity provides mechanical signals for the expansion of hemopoietic stem and progenitor cells', Nature Biotechnology, 28, pp. 1123 - 1130,
    Journal articles | 2010
    Kranias G; Watt LF; Carpenter H; Holst J; Ludowyke R; Strack S; Sim ATR; Verrills NM, 2010, 'Protein phosphatase 2A carboxymethylation and regulatory B subunits differentially regulate mast cell degranulation', Cellular Signalling, 22, pp. 1882 - 1890,
    Journal articles | 2010
    Taft RJ; Simons C; Nahkuri S; Oey H; Korbie DJ; Mercer TR; Holst J; Ritchie W; Wong JJL; Rasko JEJ; Rokhsar DS; Degnan BM; Mattick JS, 2010, 'Nuclear-localized tiny RNAs are associated with transcription initiation and splice sites in metazoans', Nature Structural and Molecular Biology, 17, pp. 1030 - 1034,
    Journal articles | 2010
    Tiffen JC; Bailey CG; Ng C; Rasko JEJ; Holst J, 2010, 'Luciferase expression and bioluminescence does not affect tumor cell growth in vitro or in vivo', Molecular Cancer, 9,
    Journal articles | 2010
    Tiffen JC; Bailey CG; Ng C; Watson SL; Loukinov DI; Lobanenkov VV; Holst J; Rasko JEJ, 2010, 'BORIS and its paralogue CTCF exhibit similar biological functions', EJC SUPPLEMENTS, 8, pp. 176 - 177,
    Journal articles | 2010
    Vanslambrouck JM; Bröer A; Thavyogarajah T; Holst J; Bailey CG; Bröer S; Rasko JEJ, 2010, 'Renal imino acid and glycine transport system ontogeny and involvement in developmental iminoglycinuria', Biochemical Journal, 428, pp. 397 - 407,
    Journal articles | 2010
    Wang H; Holst J; Woo SR; Guy C; Bettini M; Wang Y; Shafer A; Naramura M; Mingueneau M; Dragone LL; Hayes SM; Malissen B; Band H; Vignali DAA, 2010, 'Tonic ubiquitylation controls T-cell receptor: CD3 complex expression during T-cell development', EMBO Journal, 29, pp. 1285 - 1298,
    Journal articles | 2009
    Rajasekhar M; Holst J; Rasko JEJ, 2009, 'MicroRNA expression in myeloid differentiation', CYTOKINE, 48, pp. 78 - 78,
    Journal articles | 2008
    Holst J; Wang H; Eder KD; Workman CJ; Boyd KL; Baquet Z; Singh H; Forbes K; Chruscinski A; Smeyne R; van Oers NSC; Utz PJ; Vignali DAA, 2008, 'Scalable signaling mediated by T cell antigen receptor-CD3 ITAMs ensures effective negative selection and prevents autoimmunity', Nature Immunology, 9, pp. 658 - 666,
    Journal articles | 2006
    El Kasmi KC; Holst J; Coffre M; Mielke L; De Pauw A; Lhocine N; Smith AM; Rutschman R; Kaushal D; Shen Y; Suda T; Donnelly RP; Myers MG; Alexander W; Vignali DAA; Watowich SS; Ernst M; Hilton DJ; Murray PJ, 2006, 'General nature of the STAT3-activated anti-inflammatory response', Journal of Immunology, 177, pp. 7880 - 7888,
    Journal articles | 2006
    Holst J; Szymczak-Workman AL; Vignali KM; Burton AR; Workman CJ; Vignali DAA, 2006, 'Generation of T-cell receptor retrogenic mice', Nature Protocols, 1, pp. 406 - 417,
    Journal articles | 2006
    Holst J; Vignali KM; Burton AR; Vignali DAA, 2006, 'Erratum: Rapid analysis of T-cell selection in vivo using T cell-receptor retrogenic mice (Nature Methods) (2006) vol. 3 (191-197))', Nature Methods, 3, pp. 327,
    Journal articles | 2006
    Holst J; Vignali KM; Burton AR; Vignali DAA, 2006, 'Rapid analysis of T-cell selection in vivo using T cell-receptor retrogenic mice.', Nature methods, 3, pp. 191 - 197,
    Journal articles | 2003
    Sim A; Holst JA; Ludowyke RI, 2003, 'Protein phosphatase translocation in RBL-2H3 cells', Methods in Enzymology, 366, pp. 113 - 124
    Journal articles | 2003
    Sim ATR; Baldwin ML; Rostas JAP; Holst J; Ludowyke RI, 2003, 'The role of serine/threonine protein phosphatases in exocytosis', Biochemical Journal, 373, pp. 641 - 659,
    Journal articles | 2003
    Sim ATR; Holst J; Ludowyke RI, 2003, '[10] Protein Phosphatase Translocation in RBL-2H3 Cells', Methods in Enzymology, 366, pp. 113 - 124,
    Journal articles | 2002
    Holst J; Sim ATR; Ludowyke RI, 2002, 'Protein phosphatases 1 and 2A transiently associate with myosin during the peak rate of secretion from mast cells', Molecular Biology of the Cell, 13, pp. 1083 - 1098,
    Journal articles | 2000
    Ludowyke RI; Holst J; Mudge LM; Sim ATR, 2000, 'Transient translocation and activation of protein phosphatase 2A during mast cell secretion', Journal of Biological Chemistry, 275, pp. 6144 - 6152,
  • Conference Abstracts | 2024
    Persson ML; Jackson ER; Duchatel RJ; de la Nava D; Thomas BC; Savary C; McEwen HP; Beitaki TS; Kearney PS; Findlay IJ; Douglas AM; Larsen MR; Faridi P; Holst J; Mayall J; Hondermarck H; Horvat J; Nixon B; Cartaxo RT; Nazarian J; Hulleman E; Mueller S; Vitanza NA; Koshmann C; Alonso MM; Carvalheiro T; van der Lugt J; Dun MD, 2024, 'DIPG-36. DRD2 ANTAGONISM RESCUES IMMUNE-TUMOR SURVEILLANCE, WARMING THE TUMOR IMMUNE MICROENVIRONMENT OF DIFFUSE MIDLINE GLIOMA MODELS', in Neuro-Oncology, Oxford University Press (OUP), Vol. 26,
    Preprints | 2024
    Wahi K; Freidman N; Wang Q; Devadason M; Quek L-E; Pang A; Lloyd L; Larance M; Zanini F; Harvey K; O’Toole S; Guan YF; Holst J, 2024, Macropinocytosis mediates resistance to loss of glutamine transport in triple-negative breast cancer,
    Preprints | 2024
    Xie Y; Habibalahi A; Anwer A; Wahi K; Gatt C; Johansson E; Holst J; Goldys E; Zanini F, 2024, Integration of hyperspectral imaging and transcriptomics from individual cells with HyperSeq,
    Other | 2023
    Balaban S; Nassar ZD; Zhang AY; Hosseini-Beheshti E; Centenera MM; Schreuder M; Lin H-M; Aishah A; Varney B; Liu-Fu F; Lee LS; Nagarajan SR; Shearer RF; Hardie R-A; Raftopulos NL; Kakani MS; Saunders DN; Holst J; Horvath LG; Butler LM; Hoy AJ, 2023, Data from Extracellular Fatty Acids Are the Major Contributor to Lipid Synthesis in Prostate Cancer, ,
    Other | 2023
    Balaban S; Nassar ZD; Zhang AY; Hosseini-Beheshti E; Centenera MM; Schreuder M; Lin H-M; Aishah A; Varney B; Liu-Fu F; Lee LS; Nagarajan SR; Shearer RF; Hardie R-A; Raftopulos NL; Kakani MS; Saunders DN; Holst J; Horvath LG; Butler LM; Hoy AJ, 2023, Supplementary Figures 1-3 from Extracellular Fatty Acids Are the Major Contributor to Lipid Synthesis in Prostate Cancer, ,
    Other | 2023
    Balaban S; Nassar ZD; Zhang AY; Hosseini-Beheshti E; Centenera MM; Schreuder M; Lin H-M; Aishah A; Varney B; Liu-Fu F; Lee LS; Nagarajan SR; Shearer RF; Hardie R-A; Raftopulos NL; Kakani MS; Saunders DN; Holst J; Horvath LG; Butler LM; Hoy AJ, 2023, Supplementary Figures 1-3 from Extracellular Fatty Acids Are the Major Contributor to Lipid Synthesis in Prostate Cancer, ,
    Other | 2023
    Dylgjeri E; Kothari V; Shafi AA; Semenova G; Gallagher PT; Guan YF; Pang A; Goodwin JF; Irani S; McCann JJ; Mandigo AC; Chand S; McNair CM; Vasilevskaya I; Schiewer MJ; Lallas CD; McCue PA; Gomella LG; Seifert EL; Carroll JS; Butler LM; Holst J; Kelly WK; Knudsen KE, 2023, Data from A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate Cancer, ,
    Other | 2023
    Dylgjeri E; Kothari V; Shafi AA; Semenova G; Gallagher PT; Guan YF; Pang A; Goodwin JF; Irani S; McCann JJ; Mandigo AC; Chand S; McNair CM; Vasilevskaya I; Schiewer MJ; Lallas CD; McCue PA; Gomella LG; Seifert EL; Carroll JS; Butler LM; Holst J; Kelly WK; Knudsen KE, 2023, Supplementary Figure from A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate Cancer, ,
    Other | 2023
    Dylgjeri E; Kothari V; Shafi AA; Semenova G; Gallagher PT; Guan YF; Pang A; Goodwin JF; Irani S; McCann JJ; Mandigo AC; Chand S; McNair CM; Vasilevskaya I; Schiewer MJ; Lallas CD; McCue PA; Gomella LG; Seifert EL; Carroll JS; Butler LM; Holst J; Kelly WK; Knudsen KE, 2023, Supplementary Figure from A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate Cancer, ,
    Other | 2023
    Dylgjeri E; Kothari V; Shafi AA; Semenova G; Gallagher PT; Guan YF; Pang A; Goodwin JF; Irani S; McCann JJ; Mandigo AC; Chand S; McNair CM; Vasilevskaya I; Schiewer MJ; Lallas CD; McCue PA; Gomella LG; Seifert EL; Carroll JS; Butler LM; Holst J; Kelly WK; Knudsen KE, 2023, Supplementary Figure from A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate Cancer, ,
    Other | 2023
    Dylgjeri E; Kothari V; Shafi AA; Semenova G; Gallagher PT; Guan YF; Pang A; Goodwin JF; Irani S; McCann JJ; Mandigo AC; Chand S; McNair CM; Vasilevskaya I; Schiewer MJ; Lallas CD; McCue PA; Gomella LG; Seifert EL; Carroll JS; Butler LM; Holst J; Kelly WK; Knudsen KE, 2023, Supplementary Figure from A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate Cancer, ,
    Other | 2023
    Dylgjeri E; Kothari V; Shafi AA; Semenova G; Gallagher PT; Guan YF; Pang A; Goodwin JF; Irani S; McCann JJ; Mandigo AC; Chand S; McNair CM; Vasilevskaya I; Schiewer MJ; Lallas CD; McCue PA; Gomella LG; Seifert EL; Carroll JS; Butler LM; Holst J; Kelly WK; Knudsen KE, 2023, Supplementary Figure from A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate Cancer, ,
    Other | 2023
    Dylgjeri E; Kothari V; Shafi AA; Semenova G; Gallagher PT; Guan YF; Pang A; Goodwin JF; Irani S; McCann JJ; Mandigo AC; Chand S; McNair CM; Vasilevskaya I; Schiewer MJ; Lallas CD; McCue PA; Gomella LG; Seifert EL; Carroll JS; Butler LM; Holst J; Kelly WK; Knudsen KE, 2023, Supplementary Figure from A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate Cancer, ,
    Other | 2023
    Dylgjeri E; Kothari V; Shafi AA; Semenova G; Gallagher PT; Guan YF; Pang A; Goodwin JF; Irani S; McCann JJ; Mandigo AC; Chand S; McNair CM; Vasilevskaya I; Schiewer MJ; Lallas CD; McCue PA; Gomella LG; Seifert EL; Carroll JS; Butler LM; Holst J; Kelly WK; Knudsen KE, 2023, Supplementary Figure from A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate Cancer, ,
    Other | 2023
    Dylgjeri E; Kothari V; Shafi AA; Semenova G; Gallagher PT; Guan YF; Pang A; Goodwin JF; Irani S; McCann JJ; Mandigo AC; Chand S; McNair CM; Vasilevskaya I; Schiewer MJ; Lallas CD; McCue PA; Gomella LG; Seifert EL; Carroll JS; Butler LM; Holst J; Kelly WK; Knudsen KE, 2023, Supplementary Table from A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate Cancer, ,
    Other | 2023
    Dylgjeri E; Kothari V; Shafi AA; Semenova G; Gallagher PT; Guan YF; Pang A; Goodwin JF; Irani S; McCann JJ; Mandigo AC; Chand S; McNair CM; Vasilevskaya I; Schiewer MJ; Lallas CD; McCue PA; Gomella LG; Seifert EL; Carroll JS; Butler LM; Holst J; Kelly WK; Knudsen KE, 2023, Supplementary Table from A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate Cancer, ,
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Data from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition,
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Data from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition,
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Figure S1 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition,
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Figure S1 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition,
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Figure S2 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition,
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Figure S2 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition,
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Figure S3 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition,
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Figure S3 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition,
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Figure S4 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition,
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Figure S4 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition,
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Supplementary Table 1 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition,
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Supplementary Table 1 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition,
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Supplementary Table 2 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition,
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Supplementary Table 2 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition,
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Supplementary Table 3 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition,
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Supplementary Table 3 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition,
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Supplementary Table 4 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition,
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Supplementary Table 4 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition,
    Other | 2023
    2023, Data from A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate Cancer, ,
    Other | 2023
    2023, Supplementary Figure from A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate Cancer, ,
    Other | 2023
    2023, Supplementary Figure from A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate Cancer, ,
    Other | 2023
    2023, Supplementary Figure from A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate Cancer, ,
    Other | 2023
    2023, Supplementary Figure from A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate Cancer, ,
    Other | 2023
    2023, Supplementary Figure from A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate Cancer, ,
    Other | 2023
    2023, Supplementary Figure from A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate Cancer, ,
    Other | 2023
    2023, Supplementary Figure from A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate Cancer, ,
    Other | 2023
    2023, Supplementary Table from A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate Cancer, ,
    Other | 2023
    2023, Supplementary Table from A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate Cancer, ,
    Conference Papers | 2022
    Persson M; Jackson E; Duchatel R; Bramberger L; McEwen H; Kearney P; Findlay I; Douglas A; Kobbe B; Wagener R; Larsen M; Faridi P; Holst J; Mayall J; Gedye C; Hondermarck H; Horvat J; Nixon B; Cartaxo R; Koschmann C; Valdes-Mora F; Ortega DG; Nazarian J; Alonso MM; Hulleman E; Van der Lugt J; Vitanza N; Mueller S; Dun M, 2022, 'ANTAGONISM OF DRD2 USING ONC201 INCREASED EXPRESSION OF ANTIGEN PRESENTATION PATHWAY PROTEINS IN DIFFUSE MIDLINE GLIOMA, RECRUITING TUMOR INFILTRATING LYMPHOCYTES IN VIVO', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, FL, Tampa, pp. 272 - 272, presented at 27th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO), FL, Tampa, 16 November 2022 - 20 November 2022,
    Conference Abstracts | 2022
    Persson M; Jackson E; Duchatel R; Bramberger L; McEwen H; Kearney P; Findlay I; Douglas A; Kobbe B; Wagener R; Larsen M; Faridi P; Holst J; Mayall J; Gedye C; Hondermarck H; Horvat J; Nixon B; Cartaxo R; Koschmann C; Valdes-Mora F; Ortega DG; Nazarian J; Alonso MM; Hulleman E; Van der Lugt J; Vitanza N; Mueller S; Dun M, 2022, 'TMIC-06. ANTAGONISM OF DRD2 USING ONC201 INCREASED EXPRESSION OF ANTIGEN PRESENTATION PATHWAY PROTEINS IN DIFFUSE MIDLINE GLIOMA, RECRUITING TUMOR INFILTRATING LYMPHOCYTES IN VIVO', in Neuro-Oncology, Oxford University Press (OUP), Vol. 24, pp. vii272 - vii272,
    Preprints | 2020
    Gillis JL; Hinneh JA; Ryan N; Irani S; Moldovan M; Shrestha R; Quek LE; Hoy AJ; Holst J; Centenera MM; Mills IG; Lynn DJ; Selth LA; Butler LM, 2020, A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growth,
    Conference Abstracts | 2020
    Mandigo AC; McNair C; Ku K; Pang A; Guan YF; Holst J; Brown M; Kelly WK; Knudsen KE, 2020, 'Molecular underpinnings of RB status as a biomarker of poor outcome in advanced prostate cancer', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, Vol. 38, presented at Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), CA, San Francisco, 13 February 2020 - 15 February 2020,
    Conference Abstracts | 2020
    Mandigo AC; McNair C; Ku K; Pang A; Guan YF; Holst J; Brown M; Kelly WK; Knudsen KE, 2020, 'Molecular underpinnings of RB status as a biomarker of poor outcome in advanced prostate cancer.', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 38, pp. 189 - 189,
    Conference Abstracts | 2019
    van Geldermalsen M; Quek L-E; Turner N; Balaban S; Hoy A; Pang A; Guan YF; Wahi K; Wang Q; Holst J, 2019, 'Vulnerabilities in glutamine metabolism define triple-negative from Luminal A breast cancer subsets', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, TX, San Antonio, Vol. 80, presented at 42nd Annual San Antonio Breast Cancer Symposium, TX, San Antonio, 09 December 2019 - 14 December 2019,
    Conference Abstracts | 2018
    Akerman A; Sharbeen G; Holst J; Youkhana J; McCarroll J; Goldstein D; Erkan M; Phillips P, 2018, 'Targeting a solute carrier to metabolically reprogram tumour-promoting stromal cells in pancreatic cancer', in Pancreatology, Elsevier BV, Vol. 18, pp. S156 - S156,
    Conference Papers | 2018
    Geldermalsen MV; Quek L-E; Turner N; Balaban S; Hoy A; Wang Q; Holst J, 2018, 'Abstract B20: Glutamine metabolic vulnerabilities define triple-negative from luminal A breast cancer subsets', in Molecular Cancer Research, American Association for Cancer Research (AACR), pp. B20 - B20,
    Conference Papers | 2018
    Guo D; Lui GY; Sharp DM; Lai SL; Tikoo S; Kwan R; van Geldermalsen M; Holst J; Haass NK; Weninger W; Beaumont KA, 2018, 'Rab27a promotes melanoma cell invasion and metastasis via the regulation of exosome secretion', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, IL, Chicago, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), IL, Chicago, 14 April 2018 - 18 April 2018,
    Conference Papers | 2018
    Wang QK; Geldermalsen MV; Pang A; Zhang B; Holst J, 2018, 'Abstract A036: Blocking DNA and RNA synthesis by targeting glutamine metabolism in prostate cancer', in Cancer Research, American Association for Cancer Research (AACR), pp. A036 - A036,
    Conference Papers | 2017
    Wang QK; van Geldermalsen M; Pang A; Zhang B; Holst J, 2017, 'Blocking DNA and RNA synthesis by targeting glutamine metabolism in prostate cancer.', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, FL, Orlando, pp. 43 - 43, presented at AACR Special Conference on Prostate Cancer - Advances in Basic, Translational, and Clinical Research, FL, Orlando, 02 December 2017 - 05 December 2017,
    Conference Papers | 2017
    van Geldermalsen M; Quek L-E; Turner N; Balaban S; Hoy A; Wang Q; Holst J, 2017, 'Glutamine metabolic vulnerabilities define triple-negative from luminal A breast cancer subsets.', in MOLECULAR CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, CA, Hollywood, pp. 72 - 72, presented at AACR Special Conference on Advances in Breast Cancer Research, CA, Hollywood, 07 October 2017 - 10 October 2017,
    Conference Papers | 2016
    Otte NJ; Broer A; O'Young P; van Geldermalsen M; Wang Q; Bailey CG; Broer S; Holst J, 2016, 'The amino acid transporter SNAT4: Potential role as a tumor suppressor in melanoma', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, LA, New Orleans, presented at AACR 107th Annual Meeting on Bioinformatics and Systems Biology, LA, New Orleans, 16 April 2016 - 20 April 2016,
    Conference Papers | 2016
    van Geldermalsen M; Wang Q; Holst J, 2016, 'Targeting ASCT2-mediated glutamine uptake and metabolism in breast cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, LA, New Orleans, presented at AACR 107th Annual Meeting on Bioinformatics and Systems Biology, LA, New Orleans, 16 April 2016 - 20 April 2016,
    Conference Abstracts | 2015
    Colas C; Grewer C; Gameiro A; Albers T; Singh K; Otte NJ; Shere H; Massimiliano B; Holst J; Schlessinger A, 2015, 'Ligand Discovery for the Alanine-Serine-Cysteine Transporter (ASCT2, SLC1A5) from Homology Modeling and Virtual Screening', in BIOPHYSICAL JOURNAL, CELL PRESS, Vol. 108, pp. 54A - 54A,
    Conference Papers | 2015
    Hardie R-A; Wang Q; Otte N; Simmons M; Holst J, 2015, 'Targeting adaptive nutrient metabolism pathways as a therapy for prostate cancer', in BJU INTERNATIONAL, WILEY-BLACKWELL, AUSTRALIA, Cairns, pp. 47 - 47, presented at 2nd Prostate Cancer World Congress (PCWC), AUSTRALIA, Cairns, 17 August 2015 - 21 August 2015,
    Conference Papers | 2015
    Wang Q; Hardie R-A; Hoy A; Fazli L; Bailey C; Rasko JEJ; Holst J, 2015, 'Targeting amino acid transport to block mTORC1 and cell cycle in prostate cancer', in MOLECULAR CANCER THERAPEUTICS, AMER ASSOC CANCER RESEARCH,
    Conference Papers | 2015
    Wang Q; van Geldermalsen M; Otte NJ; Hardie R-A; Zhang K; Holst J, 2015, 'Regulation of amino acid uptake coordinates adaptive cancer cell metabolism', in AMINO ACIDS, SPRINGER WIEN, pp. 1625 - 1625,
    Conference Papers | 2015
    Wang QK; Hardie R-A; Hoy AJ; van Geldermalsen M; Gao D; Fazli L; Sadowski MC; Balaban S; Schreuder M; van Geldermalsen M; Otte NJ; Lehman ML; Gleave M; Nelson CC; Bailey CG; Ritchie W; Rasko JEJ; Holst J, 2015, 'Inhibition of ASCT2-mediated glutamine uptake blocks prostate cancer growth', in BJU INTERNATIONAL, WILEY-BLACKWELL, AUSTRALIA, Cairns, pp. 32 - 32, presented at 2nd Prostate Cancer World Congress (PCWC), AUSTRALIA, Cairns, 17 August 2015 - 21 August 2015,
    Conference Papers | 2015
    Zhang K; Moran A; Holst J; Wang Q, 2015, 'PI3K/Akt signalling regulates leucine transport in prostate cancer', in BJU INTERNATIONAL, WILEY-BLACKWELL, AUSTRALIA, Cairns, pp. 34 - 35, presented at 2nd Prostate Cancer World Congress (PCWC), AUSTRALIA, Cairns, 17 August 2015 - 21 August 2015,
    Conference Abstracts | 2015
    van Geldermalsen M; Wang Q; Bailey CG; Feng Y; Nagarajah R; Marshall A; Thoeng A; O'Toole S; Rasko JEJ; Holst J, 2015, 'Targeting the ASCT2 glutamine uptake and metabolism pathway in triple-negative breast cancer', in Annals of Oncology, Vol. 26, pp. iii31,
    Conference Papers | 2013
    Klein A; Hambley TW; Bierbach U; Holst J, 2013, 'Novel Amidinediaminetricarboxylato Platinum(IV)-Anthraquinone Complexes for Targeting Tumours', in JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, SPRINGER, FRANCE, Grenoble, pp. S665 - S665, presented at 16th International Conference on Biological Inorganic Chemistry (ICBIC), FRANCE, Grenoble, 22 July 2013 - 26 July 2013,
    Conference Papers | 2013
    Wang QK; Font J; Grkovic T; Pouwer R; Jormakka M; Ryan R; Rasko J; Quinn R; Holst J, 2013, 'Novel LAT3 inhibitor suppresses prostate cancer cell proliferation', in BJU INTERNATIONAL, WILEY-BLACKWELL, pp. 43 - 43,
    Conference Papers | 2012
    Rasko J; Wong J; Ritchie W; Olivia E; Matthias S; Wong JWH; Huang Y; Gao D; Gonzalez M; Baidya K; Theong A; Khoo T-L; Bailey CG; Holst J, 2012, 'Intron Retention Coupled with Nonsense-Mediated Decay Determines Protein Expression and Nuclear Morphology in Granulopoiesis', in BLOOD, AMER SOC HEMATOLOGY, GA, Atlanta, presented at 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), GA, Atlanta, 08 December 2012 - 11 December 2012,
    Conference Abstracts | 2011
    Ardjmand A; Bock CED; Molloy TJ; Bone SM; Johnstone D; Campbell DM; Shipman KL; Yeadon TM; Holst J; Spanevello MD; Catchpoole DR; Lincz LF; Boyd AW; Burns GF; Thorne RF, 2011, 'Altered expression of Fat1 cadherin, a novel tumor marker for acute lymphoblastic leukemia', in Clinical Biochemistry, Elsevier BV, Vol. 44, pp. S71 - S71,
    Conference Abstracts | 2010
    Tiffen JC; Bailey CG; Ng C; Watson SL; Loukinov DI; Lobanenkov VV; Holst J; Rasko JEJ, 2010, 'BORIS and its paralogue CTCF exhibit similar biological functions', in EJC SUPPLEMENTS, PERGAMON-ELSEVIER SCIENCE LTD, NORWAY, Oslo, Vol. 8, pp. 176 - 177, presented at 21st Meeting of the European-Association-for-Cancer-Research, NORWAY, Oslo, 26 June 2010 - 29 June 2010,
    Conference Papers | 2009
    Bailey CG; Tiffen JC; Ng C; Holst J; Rasko JEJ, 2009, 'INCORPORATING 2A PEPTIDE SEQUENCES INTO LENTIVIRAL VECTORS FOR EFFICIENT MOLECULAR IMAGING IN VIVO', in JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, AUSTRALIA, Sydney, pp. 845 - 846, presented at 6th Meeting of the Australasian-Gene-Therapy-Society, AUSTRALIA, Sydney, 29 April 2009 - 01 May 2009,
    Conference Papers | 2002
    Holst J; Sim AT; Ludowyke RI, 2002, 'Regulation of myosin phosphorylation by protein phosphatase 2a in mast cells', in MOLECULAR BIOLOGY OF THE CELL, AMER SOC CELL BIOLOGY, CALIFORNIA, SAN FRANCISCO, pp. 53A - 53A, presented at 42nd Annual Meeting of the American-Society-for-Cell-Biology, CALIFORNIA, SAN FRANCISCO, 14 December 2002 - 18 December 2002,

NHMRC/MRFF ABC Brain Cancer Grant, A new targeted combination therapy with matched biomarker to treat intractable glioblastoma. Jan 2023-Dec 2024 (CIA)

Cancer Council NSW Project Grant, Targeting the metabolic adaptations that drive anti-androgen resistance in prostate cancer. Jan 2023-Dec 2025 (CIA)

NBCF Investigator Initiated Grant, Using a physiological Ex Vivo Clinical Trial Platform to EViCT breast cancer. Jan 2023-Dec 2025 (CIA)

Tour de Cure Senior Research Grant, Developing the ultimate cancer "indoor trainer" setup to personalise cancer therapies. Jan 2023-Dec 2024 (CIA)

Charlie Teo Foundation Pilot Grant,Developing a metabolic roadmap to discover novel therapeutic avenues to starve glioblastoma. Jan 2021-Jun 2023 (CIA)

Tour de Cure Senior Research Grant, A new therapy targeting “gluttonous” prostate cancer cells Jan 2020-Dec 2020(CIA)

Cancer Council NSW Project Grant, Targeting glutamine addiction of triple-negative breast cancer (TNBC). Jan 2018-Dec 2020(CIA)

Cancer Council NSW Project Grant, Nutrient stress-mediated adaptive responses as novel targets in BRAF mutant melanoma. July 2017-Dec 2020(CIA)

NHMRC/MRFF Lifting Clinical Trials and Registries Capacity Grant, Immunotherapy Targeting of Cytomegalovirus antigens in Glioblastoma: INTERROGATE-GBM. June 2018-June 2023(CIC)

NHMRC Project Grant APP1144108 Metabolically Reprogramming the Stroma to Starve Pancreatic Tumours. Jan 2018-Dec 2020(CID)

Avner Pancreatic Cancer Foundation, Starvation of pancreatic tumours by metabolically reprogramming both tumour and stromal cells. January 2019-December 2020(CIC)

The Translational Cancer Metabolism Laboratoryis focussed on understanding the role of amino acid uptake and metabolism in melanoma, breast and prostate cancer. The lab examines the basic biology regulating amino acid transporter expression and function, the downstream metabolic pathways, as well as developing new therapeutics to target the transporters and metabolic processes.

Key Publications:

Quek LE, van Geldermalsen M, Guan YF, Wahi K, Mayoh C, Balaban S, Pang A, Wang Q, Cowley MJ, Brown KK, Turner N, Hoy AJ,Holst J. Glutamine addiction promotes glucose oxidation in triple-negative breast cancer. Oncogene, 41(34):4066-78,2022.

Wang Q, Guan YF, Hancock SE, Wahi K, van Geldermalsen M, Zhang BK, Pang A, Nagarajah R, Mak B, Freidman N, Horvath LG, Turner N,Holst J. Inhibition of guanosine monophosphate synthetase (GMPS) blocks glutamine metabolism and prostate cancer growth.The Journal of Pathology, 254(2):135-146,2021.

Zhang BK, Moran AM, Bailey CG, Rasko JEJ, Holst J*, Wang Q*.EGF-activated PI3K/Akt signaling coordinates leucine uptake by regulating LAT3 expression in prostate cancer. Cell Communication and Signaling, 17(1):83, 2019. *=Co-Senior Author

van Geldermalsen M, Quek LE, Turner N, Freidman N, Pang A, Guan YF, Krycer JR, Ryan R, Wang Q,HolstJ. Benzylserine inhibits breast cancer cell growth by disrupting intracellular amino acid homeostasis and triggering amino acid response pathways.BMC Cancer, 18(1):689,2018.

Marshall AD, van Geldermalsen M, Otte NJ, Lum T, Vellozzi M, Thoeng A, Pang A, Nagarajah R, Zhang B, Wang Q, Anderson L, Rasko JEJ,Holst J. ASCT2 Regulates Glutamine Uptake and Cell Growth in Endometrial Carcinoma.Oncogenesis, 6(7):e367,2017.

van Geldermalsen M, Wang Q, Nagarajah R, Marshall A, Thoeng A, Gao D, Ritchie W, Feng Y, Bailey CG, Deng N, Harvey K, Beith JM, Selinger C, O’Toole S, Rasko JEJ,Holst J. ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer.Oncogene, 35(24):3201-8,2016.

Wang Q, Hardie R-A, Hoy AJ, van Geldermalsen M, Gao D, Fazli L, Sadowski MC, Balaban S, Schreuder M, Nagarajah R, Wong JJ-L, Metierre C, Pinello N, Otte, NJ, Lehman ML, Gleave M, Nelson CC, Bailey CG, Ritchie W, Rasko JEJ,Holst J.Targeting ASCT2-Mediated Glutamine Uptake Blocks Prostate Cancer Growth and Tumour Development.The Journal of Pathology236(3):278-89,2015.

Wang Q, Beaumont KA, Otte NJ, Font J, Bailey CG, van Geldermalsen M, Sharp DM, Tiffen JC, Ryan RM, Jormakka M, Haass NK, Rasko JEJ,Holst J. Targeting glutamine transport to suppress melanoma cell growth.International Journal ofCancer135(5):1060-71,2014.

Wang Q, Tiffen J, Bailey CG, Lehman ML, Ritchie W, Fazli L, Metierre C, Feng Y, Li E, Gleave M, Buchanan G, Nelson CC, Rasko JEJandHolst J.Targeting amino acid transport in metastatic castration-resistant prostate cancer: Effects on cell cycle, cell growth and tumor development.Journal of theNational Cancer Institute. 105(19):1463-73,2013.

Wong JJ-L, Ritchie W, Ebner OA, Selbach M, Wong JWH, Huang Y, Gao D, Pinello N, Gonzalez M, Baidya K, Thoeng A, Khoo T-L, Bailey CG,Holst J*and Rasko JEJ*.Orchestrated intron retention regulates normal granulocyte differentiation.Cell.154(3) 583-595,2013.

Wang Q, Bailey CG, Ng C, Tiffen J, Thoeng A, Minhas V, Lehman ML, Hendy SC, Buchanan G, Nelson CC, Rasko JEJandHolst J.Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport in prostate cancer progression.Cancer Research71(24):7525-36,2011

Director of Engagement and Industry Partnerships, School of Biomedical Sciences, Faculty and Medicine and Health.

My Research Supervision

Michelle Devadason (PhD student)

Aaron Khong (Honours student)

Carley Purcell (PhD student with Chaffer Lab)

Sofia Mason(PhD student with Chaffer Lab)

My Teaching

I currently teach inPharmacology, including lectures, tutorials and practicals on cancer therapeutics forPHAR3251 and PHAR3111.